文献速递烧伤创面修复

群体烧伤事件中的创面微生物学与全身抗生素预防结局

The Wound Microbiology and the Outcomes of the Systemic Antibiotic Prophylaxis in a Mass Burn Casualty Incident.
PubMed 文献 · J Burn Care Res · 2020-01-01

本文回顾31例粉尘爆炸烧伤患者(平均年龄21岁,平均烧伤面积42%TBSA)伤后1个月的病历,描述创面微生物学及全身抗生素预防(SAP)的结局。SAP使用2至14天后,创面感染率从伤后第1周的45%降至第4周的10%,伤后第1周无血流感染发生。多重耐药微生物感染见于39%患者,≥40%TBSA和接受≥2类抗生素的OR分别为41.7和9.9。SAP未预防创面或血流感染,但无死亡发生。

要点

  • 群体烧伤中多微生物及罕见病原体创面感染常见。
  • SAP使用2至14天后创面感染率从第1周45%降至第4周10%。
  • ≥40%TBSA与多重耐药感染风险显著相关(OR 41.7)。

核心结论

  • SAP未预防创面或血流感染,但本组患者无死亡发生。
  • 需随机对照研究探讨SAP对群体烧伤死亡率的影响。

研究设计与样本

  • 回顾性病历复习,31例粉尘爆炸烧伤患者,伤后随访1个月。
  • 平均年龄21岁,平均烧伤面积42%TBSA。

主要发现

  • 多微生物和罕见病原体创面感染(如Acinetobacter junii、Aeromonas sobri等)常见。
  • SAP使用2至14天后,创面感染率从伤后第1周45%降至第4周10%。
  • 伤后第1周无血流感染发生。
  • 主要创面病原体为多重耐药鲍曼不动杆菌、肺炎克雷伯菌和白色念珠菌。
  • 多重耐药微生物感染见于39%患者,≥40%TBSA的OR为41.7(95%CI 2.1-810.7,P=.01),接受≥2类抗生素的OR为9.9(95%CI 1.0-92.7,P=.04)。

临床怎么用

  • 群体烧伤中应关注多重耐药微生物感染风险,尤其≥40%TBSA或接受多类抗生素者。
  • SAP对创面或血流感染的预防作用有限,需权衡使用。

局限性

  • 回顾性设计,样本量31例。
  • SAP对死亡率的影响需随机对照研究进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

This paper describes the wound microbiology and outcome of using systemic antibiotic prophylaxis (SAP) in mass burn casualties (MBC). The charts of 31 patients (mean age: 21 years, mean burn area: 42% of the total body surface area) injured in a dust explosion were reviewed for 1 month after the burn. Polymicrobial and rare pathogen wound infections (Acinetobacter junii, Aeromonas sobri, et al) were common in MBC due to sterility breech. Following the use of SAP for 2 to 14 days after admission, there was a reduction in wound infection rate from 45% at week 1 postburn to 10% at week 4. In addition, no blood stream infection occurred in the first week after the burns. Multidrug-resistant Acinetobacter baumannii, Klebsiella pneumoniae, and Candida albicans were the top three wound pathogens cultured. Multidrug-resistant microorganism infections were found in 39% of the patients, and the odds ratios for the these infections in burn patients with more than ≥40% total body surface area and in patients receiving two or more classes of antibiotics were 41.7 (95% confidence interval [CI] = 2.1-810.7, P = .01) and 9.9 (95% CI= 1.0-92.7, P = .04), respectively. Although SAP did not prevent wound or blood stream infections, no mortality occurred in our patients. A randomized controlled study is needed to investigate the impact of SAP on burn mortality in MBC.

来源:J Burn Care Res,查看原文。版权归原作者所有。

引用

  1. Yeong EK, Sheng WH, Hsueh PR, et al. The Wound Microbiology and the Outcomes of the Systemic Antibiotic Prophylaxis in a Mass Burn Casualty Incident. J Burn Care Res. 2020. PMID: 31999335. doi:10.1093/jbcr/irz077

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。